ALSO READVivimed Labs Alathur unit completes successful USFDA visit Strides Shasun signs definitive agreements with Vivimed Labs Vivimed Labs spurts after unit successfully completes USFDA inspection Vivimed Labs intimate of successful USFDA inspection of FDF facility in Alathur Vivimed Labs provides update on scheme of amalgamation
Drug firm Strides Shasun today said it has inked a pact with Vivimed Labs to set up two joint venture firms. The first JV -- a 50:50 joint venture company in India will own a USFDA approved formulation facility in Alathur Chennai, Strides Shasun said in a regulatory filing. The second JV firm would come up in Singapore and will own various approved abbreviated new drug applications (ANDAs) and product pipeline, it added. The exercise provides additional capacity and derisks manufacturing infrastructure, the company said. The transaction is expected to close by May 31, 2017.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)